In Canada, about 3,100 people live with hemophilia. While rare, this bleeding disorder can have serious health impacts: chronic pain, limited mobility and even risk of premature death if treated inadequately.
Read the story
Read about our financial, social and environmental performance.
See how it all adds up
Read more about the change
Xultophy® now available in Canada to
support improved glycemic control, an issue facing 50 per cent of
Canadians with type 2 diabetes Jan 23, 2019
Health Canada approves TRESIBA® for
children with Type 1 diabetes Oct 01, 2018
People with diabetes can expect to live an active, independent
life if they make a commitment to diabetes management.
Ready to be challenged? At Novo Nordisk, you will get the
opportunity to build a career among talented professionals.
Join us and build a life-changing career in a global business environment.